Results 21 to 30 of about 7,554 (201)

Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants [PDF]

open access: yesOpen Biology
Immunologic self-tolerance involves signals from co-inhibitory receptors. Several T cell co-inhibitors, including PD-1, are expressed upon activation, whereas CD5 and BTLA are expressed constitutively. The relationship between constitutively expressed co-
Adeolu O. Adegoke   +14 more
doaj   +2 more sources

Picture naming: Stereoelectroencephalography and connectivity insights. [PDF]

open access: yesEpilepsia
Abstract Objective This study investigates the neural substrates of picture naming (PN) using stereoelectroencephalographic (SEEG) stimulations and evaluates the contribution of white matter (WM) fascicles related to the basal temporal language area (BTLA) to the broader functional PN network.
Mezjan I   +4 more
europepmc   +2 more sources

High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease

open access: yesFrontiers in Immunology, 2021
B and T lymphocyte attenuator (BTLA) is a co-inhibitory receptor that is expressed by lymphoid cells and regulates the immune response. Consistent with an inhibitory role for BTLA, the disease is exacerbated in BTLA-deficient lupus mice.
Lucie Aubergeon   +7 more
doaj   +1 more source

BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation – design, synthesis and biological evaluation

open access: yesBiomedicine & Pharmacotherapy, 2023
Immune checkpoints can be divided into co-stimulatory and co-inhibitory molecules that regulate the activation and effector functions of T cells. The co-inhibitory pathways mediated by ICPs are used by cancer cells to escape from immune surveillance, and therefore the blockade of these receptor/ligand interactions is one of the strategies used in the ...
Katarzyna Kuncewicz   +11 more
openaire   +2 more sources

Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer

open access: yesFrontiers in Molecular Biosciences, 2020
BackgroundB and T lymphocyte attenuator (BTLA) is a co-signaling protein belonging to the CD28 immunoglobulin superfamily. However, the role of BTLA in prognosis and immunotherapy of colorectal cancer (CRC) remains unclear.MethodsWe evaluated the ...
Jingjing Song   +3 more
doaj   +1 more source

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma

open access: yesFrontiers in Oncology, 2021
B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to the CD28 immunoglobulin superfamily. However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been widely ...
Xubin Dong   +9 more
doaj   +1 more source

BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3+ Treg Polarization

open access: yesFrontiers in Immunology, 2020
Little is known about how tuberculosis (TB) impairs dendritic cell (DC) function and anti-TB immune responses. We previously showed that the B and T lymphocyte attenuator (BTLA), an immune inhibitory receptor, is involved in TB pathogenesis.
Jun-Ai Zhang   +25 more
doaj   +1 more source

BTLA as a biomarker and mediator of sepsis-induced immunosuppression [PDF]

open access: yesCritical Care, 2013
Recent research indicates that T-lymphocyte dysfunction may contribute to sepsis-associated morbidity and mortality. B and T lymphocyte attenuator (BTLA) is a co-inhibitory receptor expressed by T lymphocytes and B lymphocytes that is important in regulating lymphocyte activation during inflammation and infection.
Sherwood, Edward R, Hotchkiss, Richard S
openaire   +2 more sources

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination [PDF]

open access: yes, 2010
The function of antigen-specific CD8+ T cells, which may protect against both infectious and malignant diseases, can be impaired by ligation of their inhibitory receptors, which include CTL-associated protein 4 (CTLA-4) and programmed cell death 1 (PD-1).
Camilla Jandus   +26 more
core   +2 more sources

Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma – results of a prospective cohort study

open access: yesArchives of Medical Science, 2021
Introduction The successful introduction of immune checkpoint blockade approaches to renal-cell carcinoma (RCC) treatment indicates the importance of molecules regulating the T cell response to RCC risk and progression.
Krzysztof Tupikowski   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy